MiR-338-3p inhibits growth of glioblastoma through targeting MAP4K3

Minerva Med. 2021 Aug;112(4):531-533. doi: 10.23736/S0026-4806.19.06251-7. Epub 2019 Sep 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Down-Regulation
  • G1 Phase Cell Cycle Checkpoints
  • Genes, Tumor Suppressor
  • Glioblastoma / genetics
  • Glioblastoma / metabolism*
  • Glioblastoma / pathology
  • Humans
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Transfection

Substances

  • MIRN338 microRNA, human
  • MicroRNAs
  • MAP4K3 protein, human
  • Protein Serine-Threonine Kinases